Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002179323> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2002179323 endingPage "195" @default.
- W2002179323 startingPage "189" @default.
- W2002179323 abstract "Favorable responses to hexamethylmelamine (HMM) have been documented in untreated as well as in alkylating agent-resistant ovarian epithelial adenocarcinoma (OvCa). Platinum-based combination therapy for OvCa has been used since 1976. Eighteen patients with OvCa were treated with HMM as salvage therapy between February 1979 and October 1981. All patients had histologically confirmed OvCa. Eleven tumors were grade III/III and seven tumors were grade II/III. Sixteen patients had received cisplatin-based combination therapy, whereas two had received doxorubicin/cyclophosphamide because of other medical conditions. HMM was used alone in 16 patients and in combination with other drugs in two patients. The initial dose of HMM was 300 mg/m2/day X 14 days when used alone and 130 mg/m2/day X 14 days when used in combination with other drugs. Six patients were treated at a reduced initial dose because of prior marrow toxicity. Adverse effects were tolerable, with 14 patients experiencing hematologic toxicity (5 mild, 5 moderate, 3 severe, 1 life threatening) and 15 patients experiencing GI toxicity (5 mild, 7 moderate, 3 severe). Only 2 patients experienced no toxicity. No objective tumor responses were observed. Four patients had progression of tumor within 4 weeks of starting therapy and 14 patients had stable disease with a mean progression-free interval of 21 weeks. Although HMM is an active drug in untreated and alkylating agent-resistant OvCa, experience suggests that HMM at the dose and schedule tested has insignificant activity in patients who have failed cisplatin-based combination therapy." @default.
- W2002179323 created "2016-06-24" @default.
- W2002179323 creator A5028832436 @default.
- W2002179323 creator A5063180871 @default.
- W2002179323 creator A5082738107 @default.
- W2002179323 date "1984-02-01" @default.
- W2002179323 modified "2023-09-28" @default.
- W2002179323 title "Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenocarcinoma resistant to combination chemotherapy" @default.
- W2002179323 cites W1674355472 @default.
- W2002179323 cites W1969844127 @default.
- W2002179323 cites W1978507365 @default.
- W2002179323 cites W2009577733 @default.
- W2002179323 cites W2046968173 @default.
- W2002179323 cites W2049208988 @default.
- W2002179323 cites W2060982021 @default.
- W2002179323 doi "https://doi.org/10.1016/0090-8258(84)90076-3" @default.
- W2002179323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6423460" @default.
- W2002179323 hasPublicationYear "1984" @default.
- W2002179323 type Work @default.
- W2002179323 sameAs 2002179323 @default.
- W2002179323 citedByCount "15" @default.
- W2002179323 crossrefType "journal-article" @default.
- W2002179323 hasAuthorship W2002179323A5028832436 @default.
- W2002179323 hasAuthorship W2002179323A5063180871 @default.
- W2002179323 hasAuthorship W2002179323A5082738107 @default.
- W2002179323 hasConcept C126322002 @default.
- W2002179323 hasConcept C141071460 @default.
- W2002179323 hasConcept C143998085 @default.
- W2002179323 hasConcept C197934379 @default.
- W2002179323 hasConcept C2776581026 @default.
- W2002179323 hasConcept C2776694085 @default.
- W2002179323 hasConcept C2776755627 @default.
- W2002179323 hasConcept C2776999253 @default.
- W2002179323 hasConcept C2778239845 @default.
- W2002179323 hasConcept C29730261 @default.
- W2002179323 hasConcept C3019864225 @default.
- W2002179323 hasConcept C71924100 @default.
- W2002179323 hasConcept C90924648 @default.
- W2002179323 hasConceptScore W2002179323C126322002 @default.
- W2002179323 hasConceptScore W2002179323C141071460 @default.
- W2002179323 hasConceptScore W2002179323C143998085 @default.
- W2002179323 hasConceptScore W2002179323C197934379 @default.
- W2002179323 hasConceptScore W2002179323C2776581026 @default.
- W2002179323 hasConceptScore W2002179323C2776694085 @default.
- W2002179323 hasConceptScore W2002179323C2776755627 @default.
- W2002179323 hasConceptScore W2002179323C2776999253 @default.
- W2002179323 hasConceptScore W2002179323C2778239845 @default.
- W2002179323 hasConceptScore W2002179323C29730261 @default.
- W2002179323 hasConceptScore W2002179323C3019864225 @default.
- W2002179323 hasConceptScore W2002179323C71924100 @default.
- W2002179323 hasConceptScore W2002179323C90924648 @default.
- W2002179323 hasIssue "2" @default.
- W2002179323 hasLocation W20021793231 @default.
- W2002179323 hasLocation W20021793232 @default.
- W2002179323 hasOpenAccess W2002179323 @default.
- W2002179323 hasPrimaryLocation W20021793231 @default.
- W2002179323 hasRelatedWork W1993377100 @default.
- W2002179323 hasRelatedWork W2023755033 @default.
- W2002179323 hasRelatedWork W2062239485 @default.
- W2002179323 hasRelatedWork W2373876840 @default.
- W2002179323 hasRelatedWork W2404780036 @default.
- W2002179323 hasRelatedWork W2411440300 @default.
- W2002179323 hasRelatedWork W2416997470 @default.
- W2002179323 hasRelatedWork W2471989939 @default.
- W2002179323 hasRelatedWork W3100395499 @default.
- W2002179323 hasRelatedWork W363598932 @default.
- W2002179323 hasVolume "17" @default.
- W2002179323 isParatext "false" @default.
- W2002179323 isRetracted "false" @default.
- W2002179323 magId "2002179323" @default.
- W2002179323 workType "article" @default.